Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
BioCardia Earnings Preview
BioCardia (NASDAQ:BCDA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Analysts estimate that BioCardia will report an earnings per share (EPS) of $-0.25.
BioCardia Announces First Canadian Clinical Site For CardiAMP Cell Therapy Heart Failure Trial
BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces the activation of Ottawa Heart Institute, the
BioCardia Announces US Patent On Imaging System For Targeting Cardiac Therapies
SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today
Recap: BioCardia Q1 Earnings
BioCardia (NASDAQ:BCDA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
BioCardia beat estimated earnings by 20.83%, reporting an EPS of $-0.19 versus an estimate of $-0.24.
BioCardia Q1 EPS $(0.19) Beats $(0.24) Estimate, Sales $60.00K Miss $130.00K Estimate
BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.24) by 20.83 percent. This is a 5.56 percent decrease over losses of $(0.18) per share from the same
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell
• Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Earnings Preview For BioCardia
BioCardia (NASDAQ:BCDA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement.
Analysts estimate that BioCardia will report an earnings per share (EPS) of $-0.24.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million.